Saturday 17 October 2026 Export LGND’s income statement to Excel — free account

Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $268.1 million, up 60.4% from fiscal 2024. In the quarter to June 2026, revenue grew 33.7%, EPS grew 868.0% and free cash flow grew 35.5%, each against the same quarter a year earlier.

295.54 2.96 −0.99%

Follow LGND

Alert me

Market cap: $6.0B
P/E: 29.5×
Fwd P/E: 54.7×
Dividend yield: —
F-score: 6/9
Altman Z: 5.45
Beneish M: −4.02
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	21.96%	17.13%	13.47%	5.42%	+8 more TTM periods Free account
Piotroski F-Score Full definition →	5	6	6	5
ROA Full definition →	12.58%	12.60%	9.95%	4.00%
ROIC Full definition →	8.19%	9.06%	3.62%	1.52%
Return on Tangible Assets Full definition →	13.98%	18.62%	15.66%	6.68%
Average Days of Receivables Full definition →	87.84	72.87	83.12	84.40
Free Cash Flow per Share Full definition →	7.15	6.77	3.15	0.62
Free Cash Flow Full definition →	143.37	134.59	60.91	12.13
Capital Expenditures Full definition →	11.65	11.09	11.56	(19.79)
Other line items
Cash ROIC Full definition →	4.14%	6.02%	2.74%	0.59%
Accounts Receivable Turnover Full definition →	4.75	5.62	5.18	5.01
Accounts Payable Turnover Full definition →	1.48	2.44	3.44	3.44
Inventory Turnover Full definition →	1.03	0.93	1.25	1.01
Average Days of Payables Full definition →	258.50	148.10	81.23	93.29
Days of Inventory on Hand Full definition →	282.08	373.24	228.95	301.76
Tax Rate Full definition →	(0.17)	(0.17)	(0.22)	(0.23)
Research and Development Expense of Revenue Full definition →	14.23%	12.11%	30.28%	32.68%
Selling, General and Administrative Expense of Revenue Full definition →	35.60%	34.42%	34.48%	37.03%
Share Based Compensation of Revenue Full definition →	18.33%	18.07%	17.48%	15.96%
Interest Coverage Full definition →	15.30	16.91	8.70	4.59
Operating CF/Net income Full definition →	0.67	0.80	0.40	0.66
Depreciation/Fixed assets Full definition →	0.00	0.00	0.00	9.09
Capex/Depreciation Full definition →	0.40	0.38	0.38	(0.63)
Revenue per Share Full definition →	14.48	13.80	13.86	12.83
Operating CF per Share Full definition →	6.57	6.21	2.55	1.63
Capex per Share Full definition →	0.58	0.56	0.60	(1.01)
Capex to Sales Full definition →	(0.04)	(0.04)	(0.04)	0.08

Show all line items

Columns are period end dates

Stockrow Weekly